Prof. Dr. Günsu KİMYON CÖMERT

1. Reevaluation of 332 patients with pure serous borderline ovarian tumors for recurrence: is there anything we missed? A multicenter study

Ceylan O., Oktar O., Ersak B., Kilic F., Cuylan Z. F., Selcuk I., et al.

Gazzetta Medica Italiana Archivio per le Scienze Mediche , cilt.185, sa.3, ss.232-240, 2026 (Scopus)

2. Impact of postoperative infection on changes in leucocyte levels in early postoperative period in patients undergoing splenectomy during cytoreductive surgery for gynaecological malignancy

Uçar Y. Ö., Arslanca T., Aytekin O., Güner G. T., Ünlü S., KİMYON CÖMERT G., et al.

BMC Cancer , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)

3. Survival Outcomes and Prognostic Factors for Patients in Early Stage Cervical Cancer: A Multicentric Study in Turkey

Ozkaya Ucar Y., Aytekin O., Yalcin N., Oktar O., Koca Yildirim H. E., Tiryaki Guner G., et al.

Diagnostics , cilt.15, sa.21, 2025 (SCI-Expanded, Scopus)

4. Advanced stage, elevated mFIB-4 score, and MMR gene loss as independent predictors of oncological outcomes in endometrioid endometrial cancer: A retrospective observational study

KİMYON CÖMERT G., Bayramoglu N., KAR İ., Kayali E., Firat Cuylan Z., Çevikkan E., et al.

Medicine (United States) , cilt.104, sa.39, 2025 (SCI-Expanded, Scopus)

5. Survival of patients with 2014 FIGO stage IIIC high-grade serous ovarian cancer who were treated with platin-based adjuvant chemotherapy

Ünsal M., Yücesoy M., Oktar O., Uçar Y., Tiryaki Güner G., Aytekin O., et al.

Turkish Journal of Medical Sciences , cilt.55, sa.2, ss.368-376, 2025 (SCI-Expanded, Scopus, TRDizin)

6. Intermediate‑risk factors affecting oncological outcome in patients with FIGO 2018 stage IB2 cervical cancer who do not receive adjuvant therapy

Tokalioglu A. A., Oktar O., Aytekin O., Alci A., Kahraman A., Ege V., et al.

Oncology Letters , cilt.29, sa.6, 2025 (SCI-Expanded, Scopus)

7. Surgery for patients with endometrioid-type endometrial cancer: is lymphadenectomy above the inferior mesenteric artery necessary?

Tokalioglu A. A., Oktar O., Unsal M., Aytekin O., Yesil B., Altas H., et al.

World Journal of Surgical Oncology , cilt.22, sa.1, 2024 (SCI-Expanded, Scopus)

8. The role of neoadjuvant chemotherapy before radical surgery in stage IB2/IIA2 squamous cell cervical cancers

ALCI A., Aytekin O., Ersak B., Kilic F., Oktar O., Caner C., et al.

BMC Women's Health , cilt.24, sa.1, 2024 (SCI-Expanded, SSCI, Scopus)

9. Does HPV-18 co-infection increase the risk of cervical pathology in individuals with HPV-16?

Gökkaya M., Alcı A., Aytekin O., Unsal M., ÇAKIR C., Oktar O., et al.

Cytopathology , cilt.35, sa.6, ss.757-760, 2024 (SCI-Expanded, Scopus)

10. Sensitivity of frozen section analysis in patients with ovarian adult granulosa cell tumor, a multi-center study

ÜREYEN I., TOPTAŞ T., Tokalıoğlu A., ŞAHİN M., Oktar O., Kole M., et al.

Archives of Gynecology and Obstetrics , cilt.310, sa.4, ss.2167-2171, 2024 (SCI-Expanded, Scopus)

11. Do HPV 16 positive/ASC-H cervical cancer screening results predict CIN 2+ better than other high-risk HPV subtypes?

Tokalıoğlu A. A., Alcı A., Oktar O., Ünsal M., Yalçın N., Aytekin O., et al.

Journal of the Turkish German Gynecology Association , cilt.25, sa.2, ss.90-95, 2024 (ESCI, Scopus, TRDizin)

12. Prognostic factors of adult granulosa cell tumors of the ovary: A Turkish retrospective multicenter study

Oktar O., Korkmaz V., Tokalıoğlu A., ÖZTÜRK Ç., Erdoğan Ö., Uçar Y., et al.

Journal of Gynecologic Oncology , cilt.35, sa.3, 2024 (SCI-Expanded, Scopus)

13. Defining the relationship between ovarian adult granulosa cell tumors and synchronous endometrial pathology: Does ovarian tumor size correlate with endometrial cancer?

Tokalioglu A. A., Oktar O., ŞAHİN M., ÖZTÜRK Ç., Erdogan O., Yildirim H. E. K., et al.

Journal of Obstetrics and Gynaecology Research , cilt.50, sa.4, ss.655-662, 2024 (SCI-Expanded, Scopus)

14. Is adjuvant chemotherapy necessary for 2014 FIGO stage IC adult granulosa cell tumor?: Multicentric Turkish study

Erdogan O., Kilic C., ÇAKIR C., Kilic F., Oktar O., Ersak B., et al.

Asia-Pacific Journal of Clinical Oncology , cilt.20, sa.1, ss.46-54, 2024 (SCI-Expanded, Scopus)

15. Effect of tumor type on response to adjuvant platinum-based chemotherapy and prognosis in patients with stage II-IV epithelial ovarian carcinoma

Aktemur G., Kilic C., Kilic F., Unsal M., KİMYON CÖMERT G., Turan T.

Ginekologia Polska , cilt.95, sa.2, ss.99-107, 2024 (SCI-Expanded, Scopus)

16. Assessment of the differences in oncologic outcomes between patients with high-grade serous ovarian carcinoma and uterine serous carcinoma

Kilic F., Ersak B., ÇAKIR C., Yuksel D., Kilic C., Korkmaz V., et al.

Journal of Obstetrics and Gynaecology Research , cilt.50, sa.1, ss.86-94, 2024 (SCI-Expanded, Scopus)

17. The surgical and clinicopathological characteristics of primary mucinous ovarian cancer: a single institution 30-year retrospective analysis

Aytekin O., Yüksel D., Oktar O., ÇAKIR C., KİMYON CÖMERT G., Korkmaz V., et al.

Journal of the Turkish German Gynecology Association , cilt.24, sa.4, ss.252-260, 2023 (ESCI, Scopus, TRDizin)

18. Clinicopathological features of atypical glandular cells, not otherwise specified, on cervicovaginal pap smears

Aytekin O., ÇAKIR C., Unsal M., Celik F., Tokalioglu A. A., Kilic F., et al.

Cytopathology , cilt.34, sa.2, ss.130-137, 2023 (SCI-Expanded, Scopus)

19. Oncologic outcome in patients with 2018 FIGO stage IB cervical cancer: Is tumor size important?

Tokalioglu A. A., Kilic C., Oktar O., Kilic F., ÇAKIR C., Yuksel D., et al.

Journal of Obstetrics and Gynaecology Research , cilt.49, sa.2, ss.709-716, 2023 (SCI-Expanded, Scopus)

20. Neoadjuvant chemotherapy in patients with stage IVB uterine serous carcinoma: a Turkish multicentric study

Unsal M., Kilic C., ÇAKIR C., Kilic F., Ersak B., Karakas S., et al.

Journal of Obstetrics and Gynaecology , cilt.43, sa.1, 2023 (SCI-Expanded, Scopus)

21. Oncologic outcomes of patients with FIGO 2014 stage IB-IIA cervical adenocarcinoma who underwent radical surgery

Yüksel D., ÇAKIR C., Kılıç F., Ünsal M., Kılıç Ç., KİMYON CÖMERT G., et al.

Archives of Gynecology and Obstetrics , cilt.306, sa.5, ss.1657-1664, 2022 (SCI-Expanded, Scopus)

22. Defining prognostic factors in older patients with endometrial cancer

Yucel Celik O., Unsal M., Kilic F., Unsal P., Aytekin O., ÇAKIR C., et al.

Irish Journal of Medical Science , cilt.191, sa.3, ss.1123-1131, 2022 (SCI-Expanded, Scopus)

23. Brenner tumors of the ovary: clinical features and outcomes in a single-center cohort

Yüksel D., Kılıç Ç., ÇAKIR C., KİMYON CÖMERT G., Turan T., ÜNLÜBİLGİN E., et al.

Journal of the Turkish German Gynecology Association , cilt.23, sa.1, ss.22-27, 2022 (ESCI, Scopus, TRDizin)

24. Evaluation of peripheral nodal recurrence in patients with endometrial cancer

Kılıç F., KİMYON CÖMERT G., Akar S., Kılıç Ç., ÇAKIR C., Yüksel D., et al.

Journal of the Turkish German Gynecology Association , cilt.23, sa.1, ss.38-50, 2022 (ESCI, Scopus, TRDizin)

25. Prognostic value of systemic inflammatory response markers in cervical cancer

Ayhan S., Akar S., KAR İ., TURAN A. T., Türkmen O., Kiliç F., et al.

Journal of Obstetrics and Gynaecology , cilt.42, sa.6, ss.2411-2419, 2022 (SCI-Expanded, Scopus)

26. Transdiaphragmatic cardiophrenic lymph node resection in a patient with an advanced-stage ovarian cancer

Turkmen O., Kilic F., Ersak B., KİMYON CÖMERT G., Ayhan S., ÖZDEMİR M., et al.

Journal of Obstetrics and Gynaecology , cilt.42, sa.3, ss.527-529, 2022 (SCI-Expanded, Scopus)

27. The effect of adjuvant radiotherapy on oncological outcomes in patients with early-stage cervical carcinoma with only intermediate-risk factors: a propensity score matching analysis

Turkmen O., Kilic F., Tokalioglu A. A., ÇAKIR C., Yuksel D., Kilic C., et al.

Journal of Obstetrics and Gynaecology , cilt.42, sa.7, ss.3204-3211, 2022 (SCI-Expanded, Scopus)

28. Post-recurrence survival analysis of patients with pulmonary recurrence from gynaecologic cancers: a multi-institutional analysis of 122 patients

Ersak B., Akar S., Demirayak G., Tokalioğlu A. A., Aytekin O., ÇAKIR C., et al.

Journal of Obstetrics and Gynaecology , cilt.42, sa.7, ss.3277-3284, 2022 (SCI-Expanded, Scopus)

29. Retrospective Analysis of Pure Ovarian Immature Teratoma in Patients Aged 15-39 Years: A Turkish Multicenter Study

Yüksel D., Ayhan S., Korkmaz V., Çaklr C., Klllç Ç., AKGÖR U., et al.

Journal of Adolescent and Young Adult Oncology , cilt.10, sa.6, ss.697-702, 2021 (SCI-Expanded, Scopus)

30. The prognostic factors in 384 patients with FIGO 2014 stage IB cervical cancer: What is the role of tumor size on prognosis?

Yüksel D., Karataş Şahin E., Ünsal M., ÇAKIR C., Kılıç Ç., KİMYON CÖMERT G., et al.

European Journal of Obstetrics and Gynecology and Reproductive Biology , cilt.266, ss.126-132, 2021 (SCI-Expanded, Scopus)

31. Prognostic factors determining survival after extrapelvic recurrence in endometrioid type endometrial cancer

Kilic F., Unsal M., ÇAKIR C., Yuksel D., Kilic C., Dur R., et al.

Taiwanese Journal of Obstetrics and Gynecology , cilt.60, sa.6, ss.1023-1030, 2021 (SCI-Expanded, Scopus)

32. What is the impact of corpus uterine invasion on oncologic outcomes in surgically treated cervical cancer?

Turan T., KİMYON CÖMERT G., Boyraz G., Kilic F., ÇAKIR C., Kilic C., et al.

Journal of Obstetrics and Gynaecology Research , cilt.47, sa.10, ss.3634-3643, 2021 (SCI-Expanded, Scopus)

33. Malignant struma ovarii: From case to analysis

Ayhan S., Kilic F., Ersak B., Aytekin O., Akar S., Turkmen O., et al.

Journal of Obstetrics and Gynaecology Research , cilt.47, sa.9, ss.3339-3351, 2021 (SCI-Expanded, Scopus)

34. Ovarian Dysgerminoma: A Tertiary Center Experience

Kilic C., ÇAKIR C., Yuksel D., Kilic F., Kayikcioglu F., KOÇ S., et al.

Journal of Adolescent and Young Adult Oncology , cilt.10, sa.3, ss.303-308, 2021 (SCI-Expanded, Scopus)

35. Recurrence pattern and prognostic factors for survival in cervical cancer with lymph node metastasis

Kilic C., KİMYON CÖMERT G., ÇAKIR C., Yuksel D., Codal B., Kilic F., et al.

Journal of Obstetrics and Gynaecology Research , cilt.47, sa.6, ss.2175-2184, 2021 (SCI-Expanded, Scopus)

36. Spotlight on oncologic outcomes and prognostic factors of pure endometrioid ovarian carcinoma

ÇAKIR C., Korkmaz V., KİMYON CÖMERT G., Yuksel D., Kilic F., Kilic C., et al.

Journal of Gynecology Obstetrics and Human Reproduction , cilt.50, sa.6, 2021 (SCI-Expanded, Scopus)

37. The role of lymphadenectomy in patients with stage III&IV uterine serous carcinoma: Results of multicentric Turkish study

ÇAKIR C., Kilic F., Kilic C., Tokgozoglu N., Ersak B., Ayhan S., et al.

Journal of Gynecology Obstetrics and Human Reproduction , cilt.50, sa.5, 2021 (SCI-Expanded, Scopus)

38. Risk factors for evisceration in gynecological oncology surgeries

Kiliç F., KİMYON CÖMERT G., Ünsal M., Kiliç Ç., ÇAKIR C., Yüksel D., et al.

Turkish Journal of Medical Sciences , cilt.51, sa.2, ss.508-517, 2021 (SCI-Expanded, Scopus, TRDizin)

39. Primary leiomyosarcoma of the uterine cervix: report of 4 cases, systematic review, and meta-analysis

Kiliç C., Yuksel D., ÇAKIR C., Turkmen O., KİMYON CÖMERT G., BAŞARAN D., et al.

Tumori , cilt.106, sa.5, ss.413-423, 2020 (SCI-Expanded, Scopus)

40. Can preoperative inflammatory markers differentiate endometrial cancer from complex atypical hyperplasia/endometrial intraepithelial neoplasia?

Selen S., Kilic F., KİMYON CÖMERT G., Unsal M., Kilic C., Karalok A., et al.

Journal of Obstetrics and Gynaecology Research , cilt.46, sa.7, ss.1148-1156, 2020 (SCI-Expanded, Scopus)

41. Unusual usage of the automated stapler in gynecologic oncology: Method for diaphragmatic full thickness implant resection without entrance to pleural space

KİMYON CÖMERT G., Karalok A., Kılıç C., BAŞARAN D., Kılıç F., Türkmen O., et al.

Journal of the Turkish German Gynecology Association , cilt.21, sa.4, ss.301-302, 2020 (ESCI, Scopus, TRDizin)

42. Which factors predict parametrial involvement in early stage cervical cancer? A Turkish multicenter study

Kilic C., ÇAKIR C., Yuksel D., Tokgozoglu N., KİMYON CÖMERT G., Karalok A., et al.

European Journal of Obstetrics and Gynecology and Reproductive Biology , cilt.243, ss.63-66, 2019 (SCI-Expanded, Scopus)

43. Blood Vessel Invasion in Endometrial Cancer Is One of the Mechanisms of Spread to the Cervix

KİMYON CÖMERT G., BAŞARAN D., Ergin Akkoz H., Celik B., Sinaci S., Turkmen O., et al.

Pathology and Oncology Research , cilt.25, sa.4, ss.1431-1436, 2019 (SCI-Expanded, Scopus)

44. High-grade uterine corpus-confined endometrial cancer with lymphadenectomy: Does adjuvant therapy improve survival? Erken evre yüksek riskli ve lenfadenektomi yapılmış endometrium kanserinde adjuvan tedavi sağkalımı iyileştirir mi?

Kılıç Ç., ÇAKIR C., Yüksel D., Durmuş Y., BORAN N., KİMYON CÖMERT G., et al.

Turkish Journal of Obstetrics and Gynecology , cilt.16, sa.3, ss.180-186, 2019 (Scopus, TRDizin)

45. The correlation between birth weight and insulin-like growth factor-binding protein-1 (IGFBP-1), kisspeptin-1 (KISS-1), and three-dimensional fetal volume

KİMYON CÖMERT G., Esin S., Caglar G. S., Yirci B., Ozdemir S., Demirtas S., et al.

Journal of Maternal-Fetal and Neonatal Medicine , cilt.32, sa.13, ss.2152-2158, 2019 (SCI-Expanded, Scopus)

46. Prognostic factors and oncological outcomes of ovarian yolk sac tumors: a retrospective multicentric analysis of 99 cases

Boyraz G., Durmus Y., Cicin I., KURU O., LEVENTOĞLU Ö. S., KİMYON CÖMERT G., et al.

Archives of Gynecology and Obstetrics , cilt.300, sa.1, ss.175-182, 2019 (SCI-Expanded, Scopus)

47. Effect of adjuvant therapy on oncologic outcomes of surgically confirmed stage I uterine carcinosarcoma: A Turkish gynecologic oncology study

KİMYON CÖMERT G., Türkmen O., Boyraz G., YALÇIN İ., Altın D., Karalök A., et al.

Balkan Medical Journal , cilt.36, sa.4, ss.229-234, 2019 (SCI-Expanded, Scopus, TRDizin)

48. Maximal cytoreduction is related to improved disease-free survival in low-grade ovarian serous carcinoma

KİMYON CÖMERT G., Turkmen O., Mesci C. G., Karalok A., Sever O., Sinaci S., et al.

Tumori , cilt.105, sa.3, ss.259-264, 2019 (SCI-Expanded, Scopus)

49. How to Handle Lymphadenectomy Specimens to Identify Metastasis More Accurately in Gynecologic Pathology

KİMYON CÖMERT G., Dincer N., USUBÜTÜN A.

International Journal of Surgical Pathology , cilt.27, sa.3, ss.244-250, 2019 (SCI-Expanded, Scopus)

50. Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients

Yüksel D., ÇAKIR C., KİMYON CÖMERT G., Kılıç Ç., Durmuş Y., BORAN N., et al.

Journal of the Turkish German Gynecology Association , cilt.20, sa.4, ss.224-230, 2019 (Scopus, TRDizin)

51. Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: A Turkish Gynecologic Oncology Group study

Ayhan A., Ozkan N. T., Öz M., KİMYON CÖMERT G., Cuylan Z. F., Çoban G., et al.

Journal of Gynecologic Oncology , cilt.29, sa.4, 2018 (SCI-Expanded, Scopus)

52. Prognostic factors and patterns of recurrence in lymphovascular space invasion positive women with stage IIIC endometriod endometrial cancer

Cuylan Z. F., Oz M., Ozkan N. T., KİMYON CÖMERT G., Sahin H., Turan T., et al.

Journal of Obstetrics and Gynaecology Research , cilt.44, sa.6, ss.1140-1149, 2018 (SCI-Expanded, Scopus)

53. The preoperative serum CA125 can predict the lymph node metastasis in endometrioid-type endometrial cancer

Ünsal M., KİMYON CÖMERT G., Karalok A., BAŞARAN D., Turkmen O., Boyraz G., et al.

Ginekologia Polska , cilt.89, sa.11, ss.599-606, 2018 (SCI-Expanded, Scopus)

54. Recurrence in uterine tumors with ovarian sex-cord tumor resemblance: A case report and systematic review

KİMYON CÖMERT G., Kiliç Ç., Çavuşoğlu D., Türkmen O., Karalok A., Turan T., et al.

Turk Patoloji Dergisi , cilt.34, sa.3, ss.225-233, 2018 (Scopus, TRDizin)

55. Prognostic factors and treatment outcomes in surgically-staged non-invasive uterine clear cell carcinoma: A Turkish gynecologic oncology group study

Sarı M. E., Meydanlı M. M., Türkmen O., KİMYON CÖMERT G., TURAN A. T., Karalök A., et al.

Journal of Gynecologic Oncology , cilt.28, sa.4, 2017 (SCI-Expanded, Scopus)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Tez Danışmanlığı

Açık Erişim